investor relations

Stock price graph

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Receptos, Inc.'s financial performance into perspective.


October 3, 2014
Receptos Announces First Patient Treated With Anti-Interleukin-13 Antibody in Phase 2 Trial for Eosinophilic Esophagitis MORE»

September 10, 2014
Receptos Announces Oral Podium Presentation at MS Boston 2014 MORE»


There are no events available at this time.